Acceso universal al Programa de VIH/SIDA de la Ciudad de México: resultados a seis años

Claudín, Carmen Soler
January 2009
Salud Pública de México;ene/feb2009, Vol. 51 Issue 1, p26
Academic Journal
Objective. To analyze the results of the Free Antiretroviral Medication Program of the Mexico City HIV/AIDS Program among the affected population in Mexico City. Material and Methods. A retrospective analysis was conducted of medical attention, antiretroviral treatment and specialized laboratory results data from 2001 to 2006 from patients who sought services from the Mexico City HIV/AIDS Program. Results. Data from 5 146 patients who were undergoing ARV are presented. At the end of the period studied, 74% were current, 12.2% were not found for follow-up and 13.9% had died. Conclusions. During the period evaluated, wider coverage was achieved in Mexico City as well as increased efficiency in ARV treatment and increased patient survival.


Related Articles

  • Updated HIV Treatment Recommendations for 2002.  // American Family Physician;12/1/2002, Vol. 66 Issue 11, p2159 

    Discusses the study 'Antiretroviral treatment for adult HIV infection in 2002. Updated recommendations of the International AIDS Society-USA Panel,' by P.G. Yeni et al., from the July 10, 2002 issue of the 'Journal of American Medical Association.'

  • HIV/AIDS 2001: Latest treatment strategies. Brown, Billy Ray; Robinson, Marvin // Drug Topics;3/19/2001, Vol. 145 Issue 6, p39 

    Presents updates on the development of treatment strategies for AIDS/HIV in 2001. Classes of antiretrovirals approved by the United States Food and Drug Administration; Study which determined the role of adherence to virologic failures in the majority of patients; Lipid management in HIV.


    In the last ten years few retroviruses have been isolated. The reasons for this lack of new discoveries are obvious, most retroviral investigations have been directed to HIV, HTLVI and HTLVII research with little research attention given to other species that may have retroviral infections, such...

  • Caring for the children. Cross, Robyn; Warriner, Jason // Nursing Standard;7/19/2006, Vol. 20 Issue 45, p23 

    KwaZulu Natal has the highest rates of HIV/AIDS in South Africa. Teams of British nurses and doctors visit the province regularly to help staff there learn about antiretroviral therapy.

  • Recent Developments in Antiretroviral Therapy. DeSimone, Gary A. // Clinical Journal of Oncology Nursing;Nov/Dec2001, Vol. 5 Issue 6, p1 

    This article reviews the antiretroviral medications in development as presented at the 8th Annual Conference on Retroviruses and Opportunistic Infections. New medications for the treatment of HIV/AIDS are discussed by classification and a brief description of its unique quality is described.

  • Treatment-Mediated Changes in Human Immunodeficiency Virus (HIV) Type 1 RNA and CD4 Cell Counts... Lindsey, Jane C.; Hughes, Michael D.; McKinney, Ross E.; Cowles, Mary K.; England, Janet A.; Baker, Carol J.; Burchett, Sandra K.; Kline, Mark W.; Kovacs, Andrea; Moye, Jack // Journal of Infectious Diseases;11/1/2000, Vol. 182 Issue 5, p1385 

    Evaluates the predictive value of antiretroviral treatment-mediated changes in 3 markers of human immunodeficiency virus type 1 disease progression. HIV-1 RNA level; CD4 cell count; CD4 percentage; Weight growth failure; Cognitive decline; Survival of HIV-infected children; Differential age...

  • Antiretroviral Therapy in AIDS. Broder, Samuel; Mitsuya, Hiroaki; Yarchoam, Robert; Pavlakis, George N. // Annals of Internal Medicine;10/15/90, Vol. 113 Issue 8, p604 

    Discusses the development of antiretroviral therapy for AIDS and related disorders. Summary of a Clinical Staff Conference on October 26, 1988 at the National Institutes of Health; Emergence of drug-resistant virus variants; Description of the activity of 2', 3'-dideoxynucleosides against other...

  • The HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind's future? De Groot, Natasja G.; Bontrop, Ronald E. // Retrovirology;2013, Vol. 10 Issue 1, p1 

    An HIV-1 infection progresses in most human individuals sooner or later into AIDS, a devastating disease that kills more than a million people worldwide on an annual basis. Nonetheless, certain HIV-1-infected persons appear to act as long-term non-progressors, and elite control is associated...

  • Strengthening adherence to Anti Retroviral Therapy (ART) monitoring and support: operation research to identify barriers and facilitators in Nepal. Bam, Kiran; Rajbhandari, Rajesh M.; Karmacharya, Dibesh B.; Dixit, Sameer M. // BMC Health Services Research;2015, Vol. 15 Issue 1, p1 

    Background: Anti Retroviral Therapy (ART) is the cornerstone for comprehensive health sector response to Human Immunodeficiency Virus (HIV) treatment, care and support. Adherence of at least 95% is needed to keep HIV under control, as per World Health Organization (WHO) guidelines. This study...

  • CLINICAL CARE OF MEN LIVING WITH HIV/AIDS, WHO HAVE SEX WITH WOMEN, IN SÃO PAULO, BRAZIL. Segurado, A.; Nascimento, V.; Batistela, E.; Braga, P.; Bosco, S.; Elvira, F.; Naila, S.; Vera, P. // Journal of Epidemiology & Community Health;Aug2004 Supplement 1, Vol. 58, pA117 

    The article presents study related to clinical care of men with HIV/AIDS. The core of people living with HIV/AIDS in Brazil, following guidelines issued by National Ministry of Health, has brought about a significant reduction in the morbidity and mortality associated with this retroviral...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics